Validation of a Psychological Fragility Questionnary in the Elderly in Isolation

Loneliness Clinical Trial

— MUTAC  

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT02914080
• Other study ID #: 14-PP-09
• Status: Completed
• Start date: November 2014
• Est. completion date: June 2018

Study information

• Verified date: July 2018
• Source: Centre Hospitalier Universitaire de Nice
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

Social isolation and loneliness of the elderly have become major public health problems, because of the deleterious consequences if not lethal they can generate.

Because of frequent resignation to these phenomena, support must be given to all means of prevention to prevent or at least mitigate their impacts. It appears from the literature that are isolated or living as they have adjustment difficulties which are linked to fragility. If geriatric frailty have been defined to date in somatic and cognitive criteria, psychological fragility criteria have been little discussed outside of psychiatric disorders (depression, anxiety disorders in particular).

This study aims to test in the elderly in isolation psychological fragility questionnaire and to study the statistical qualities and relations with socio-demographic variables, environmental and other known vulnerabilities.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 300
• Est. completion date: June 2018
• Est. primary completion date: November 2016
• Accepts healthy volunteers: No
• Gender: All
• Age group: 65 Years and older

Eligibility

Inclusion Criteria:

• People over 65

• Living alone at home (rural and urban ) or institution ( nursing home , no family member or spouse in the same institution).

• No not refusing to participate in the survey

Exclusion Criteria:

• Overt or decompensated psychiatric pathology: major depressive disorder , bipolar disorder, psychotic disorder, severe personality disorder , primary addiction ( ICD-10 criteria)

• Alzheimer's disease or related illness probable or confirmed (ICD criteria 10)

• Sequel to severe neurological disease , unstabilized somatic pathology and / or may disrupt data collection

• Patients do not have the capacity to understand the objectives of the survey

Related Conditions & MeSH terms

• Loneliness

Locations

Country	Name	City	State
France	CHU Nice	Nice

Sponsors (1)

Lead Sponsor	Collaborator
Centre Hospitalier Universitaire de Nice

Country where clinical trial is conducted

France, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Psychological scales used to evaluate the elements of fragility in the elderly in isolation		2 years